Mortality in carotid sinus hypersensitivity: a cohort study
Joanna L Hampton1, Carol Brayne, Michelle Bradley
1Department of Geriatric Medicine, Addenbrookes Hospital, Cambridge, UK.
BMJ Open
|October 25, 2011
Summary
Carotid sinus hypersensitivity (CSH) in older adults does not increase mortality risk compared to the general population. Survival rates are similar across different CSH subtypes, confirming its neutral effect on lifespan.
Area of Science:
- Cardiology
- Geriatrics
- Epidemiology
Background:
- Carotid sinus hypersensitivity (CSH) is a prevalent condition in elderly individuals.
- Previous research suggests a potential link between CSH and increased mortality, warranting further investigation.
Purpose of the Study:
- To investigate the mortality rates of patients with CSH compared to a matched general population cohort.
- To determine if different subtypes of CSH are associated with varying survival outcomes.
Main Methods:
- A retrospective cohort study involving 1504 patients diagnosed with CSH between 1990 and 2001.
- Comparison of mortality data with geographically and age-matched controls from the Office of National Statistics.
- Analysis of survival curves using Kaplan-Meier methods and calculation of standardized mortality ratios (SMRs).
Main Results:
- No significant difference in all-cause, cerebrovascular, or cardiovascular mortality was observed between CSH patients and the general population (SMRs).
- Survival rates did not differ significantly among the three identified subtypes of CSH (p=0.2).
Conclusions:
- CSH is not associated with an increased risk of mortality in older adults.
- There is no evidence to suggest differential mortality risks based on CSH subtypes.
- These findings reinforce the understanding of CSH as having a neutral effect on overall mortality.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...